OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE) — FDA Approval ANDA211062 (HIBROW HLTHCARE)
OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE) — FDA Approval ANDA211062 (HIBROW HLTHCARE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: OXYBUTYNIN CHLORIDE; Active ingredients: OXYBUTYNIN CHLORIDE; Application number: ANDA211062.
| Brand name | OXYBUTYNIN CHLORIDE |
|---|---|
| Active ingredients | OXYBUTYNIN CHLORIDE |
| Application number | ANDA211062 |
| Sponsor | HIBROW HLTHCARE |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20190206 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →